Prophetic... That's what analyst Sean McCloskey can be at times with his market predictions, and while at this point it's pretty obvious to him, folks still aren't listening...
By Sean McCloskey
Updated June 11, 2021
Truth is, if investment analysts were boxers, Energy and Capital would be the gym where Floyd Mayweather, Mike Tyson, and Muhammad Ali trained. Yeah, we’re that good. And we have the track records to prove it.
By Jeff Siegel on June 10, 2021
Energy and Capital editor Keith Kohl shows investors a new source of lithium that billionaires like Elon Musk are salivating over.
By Keith Kohl on June 9, 2021
Many oil companies are selling at 60%–80% discounts from their highs at a time when oil prices are about to take off. Now is the time to put your money to work in oil.
By Christian DeHaemer on June 8, 2021
Until the second quarter of 2022 — that’s how long Gartner analysts predict the current semiconductor shortage will last. With demand only increasing, this means a surge for the semi stocks. This overlooked company down nearly 20% is editor Sean McCloskey’s No. 1 play during the shortage.
By Sean McCloskey on June 7, 2021
Who likes to short the shorts? R/WallStreetBets and its band of Reddit revolutionaries do. The gains these folks are banking are huge, and you can join them. Today, analyst Sean McCloskey breaks down the insider moves this group of rebel traders is going to make next.
By Sean McCloskey on June 4, 2021
While market analyst Jeff Siegel certainly has exposure to a couple CSE-listed psychedelics stocks, the lion’s share of his psychedelics investments are focused on the companies that are either already on senior exchanges or soon will be. Because that, quite frankly, is where you’re going to get the most bang for your buck.
By Jeff Siegel on June 3, 2021
|
Wyoming Bets Millions It Can Bully Other States Into Taking Its Coal
Written By
Jeff Siegel
Posted May 3, 2021 |
|
|
Vikings, Teslas, and the Quest for the Perfect Electric Car Stock
Written By
Jeff Siegel
Posted January 6, 2021 |
|
|
It was Stupid to Underestimate Jaguar Health (NASDAQ: JAGX)
Written By
Jeff Siegel
Posted January 5, 2021 |
